Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 120 for:    tenaya
Previous Study | Return to List | Next Study

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03823287
Recruitment Status : Recruiting
First Posted : January 30, 2019
Last Update Posted : June 20, 2019
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 31, 2021
  Estimated Study Completion Date : November 30, 2022